Watch Ticker

LAVA Therapeutics N.V. Ordinary Shares

Go to LAVA Therapeutics N.V. Ordinary Shares Website

$1.52

0.02 (1.00%)

Live

Previous Close

$1.505

Day Range

$1.45 - $1.56

Previous Day Range

$1.42 - $1.5399

Market Cap

$38.7 million USD

Day Vol.

199303

Previous Day Vol.

321842

Currency

USD

Primary Exchange

Nasdaq

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated an...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

XOMA Royalty Corporation announced a definitive agreement to acquire LAVA Therapeutics for $1.16-$1.24 per share in cash, plus a contingent value right, with the transaction expected to close in Q4 2025.

Related tickers: XOMA, XOMAO, XOMAP, LVTX.

Read Full Article

N/A - LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

LAVA Therapeutics, a clinical-stage immuno-oncology company, announced that its CEO will present at the H.C. Wainwright 26th Annual Global Investment Conference. The company is focused on developing its Gammabody platform of bispecific gamma delta T cell engagers for the treatment of solid tumors and hematologic malignancies.

Related tickers: LVTX, MRK, PFE.

Read Full Article

Trending Tickers

Please sign in to view